EU delays clinical trial disclosures until at least March

12/18/2013 | Bloomberg Businessweek

The European Medicines Agency plans to reconvene in March to review the more than 1,100 comments it has received from drug firms, health care professionals, patient advocates and others on a policy for public disclosure of clinical trial data. The agency, which had previously aimed for a decision by Nov. 30, continues to release clinical study reports in response to specific requests.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL